A host-microbiome interaction mediates the opposing effects of omega-6 and omega-3 fatty acids on metabolic endotoxemia

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Kaliannan, Kanakaraju ^a   Wang, Bin ^a   Li, Xiang Yong ^a   Kim, Kui Jin ^a   Kang, Jing X ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ANTIINFLAMMATORY AGENT; LIPOPOLYSACCHARIDE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DIET; DIETARY SUPPLEMENT; DRUG EFFECTS; DYSBIOSIS; ENDOTOXEMIA; INFLAMMATION; INTESTINE; INTESTINE FLORA; MALE; METABOLISM; MICROBIOLOGY; MOUSE; SECRETION (PROCESS); TRANSGENIC MOUSE;

ALKALINE PHOSPHATASE; ANIMALS; ANTI-INFLAMMATORY AGENTS; DIET; DIETARY SUPPLEMENTS; DYSBIOSIS; ENDOTOXEMIA; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; GASTROINTESTINAL MICROBIOME; INFLAMMATION; INTESTINES; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC;

EID: 84931287751     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep11276     Document Type: Article

References (61)

1. Hotamisligil, G. S. Inflammation and metabolic disorders. Nature 444, 860-867, doi:10.1038/nature05485 (2006).
2. Ruiz-Nunez, B., Pruimboom, L., Dijck-Brouwer, D. A. , Muskiet, F. A. Lifestyle and nutritional imbalances associated with Western diseases: causes and consequences of chronic systemic low-grade inflammation in an evolutionary context. J Nutr Biochem 24, 1183-1201, doi:10.1016/j.jnutbio.2013.02.009 (2013).
3. Nathan, C. , Ding, A. Nonresolving inflammation. Cell 140, 871-882, doi:10.1016/j.cell.2010.02.029 (2010).
4. Cani, P. D. et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56, 1761-1772, doi:10.2337/db06-1491 (2007).
5. Jia, L. et al. Hepatocyte Toll-like receptor 4 regulates obesity-induced inflammation and insulin resistance. Nat Commun 5, 3878, doi:10.1038/ncomms4878 (2014).
6. Youm, Y. H. et al. Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging. Cell Metab 18, 519-532, doi:10.1016/j.cmet.2013.09.010 (2013).
7. Cani, P. D. et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57, 1470-1481, doi:10.2337/db07-1403 (2008).
8. de La Serre, C. B. et al. Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol 299, G440-448, doi:10.1152/ajpgi.00098.2010 (2010).
9. Moreira, A. P., Texeira, T. F., Ferreira, A. B., Peluzio Mdo, C. , Alfenas Rde, C. Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia. Br J Nutr 108, 801-809, doi:10.1017/S0007114512001213 (2012).
10. Erridge, C., Attina, T., Spickett, C. M. , Webb, D. J. A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr 86, 1286-1292 (2007).
11. Pendyala, S., Walker, J. M. , Holt, P. R. A high-fat diet is associated with endotoxemia that originates from the gut. Gastroenterology 142, 1100-1101 e1102, doi:10.1053/j.gastro.2012.01.034 (2012).
12. Calder, P. C. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 83, 1505S-1519S (2006).
13. Serhan, C. N., Chiang, N. , Van Dyke, T. E. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8, 349-361, doi:10.1038/nri2294 (2008).
14. Leaf, A. , Weber, P. C. A new era for science in nutrition. Am J Clin Nutr 45, 1048-1053 (1987).
15. Blasbalg, T. L., Hibbeln, J. R., Ramsden, C. E., Majchrzak, S. F. , Rawlings, R. R. Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. Am J Clin Nutr 93, 950-962, doi:10.3945/ajcn.110.006643 (2011).
16. Trumbo, P. et al. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids. J Am Diet Assoc 102, 1621-1630 (2002).
17. Simopoulos, A. P. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood) 233, 674-688, doi:10.3181/0711-MR-311 (2008).
18. Kang, J. X. The omega-6/omega-3 fatty acid ratio in chronic diseases: animal models and molecular aspects. World Rev Nutr Diet 102, 22-29, doi:10.1159/000327787 (2011).
19. Wall, R., Ross, R. P., Fitzgerald, G. F. , Stanton, C. Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids. Nutr Rev 68, 280-289, doi:10.1111/j.1753-4887.2010.00287.x (2010).
20. Kang, J. X. , Weylandt, K. H. Modulation of inflammatory cytokines by omega-3 fatty acids. Subcell Biochem 49, 133-143, doi:10.1007/978-1-4020-8831-5-5 (2008).
21. Rangel-Huerta, O. D., Aguilera, C. M., Mesa, M. D. , Gil, A. Omega-3 long-chain polyunsaturated fatty acids supplementation on inflammatory biomakers: a systematic review of randomised clinical trials. Br J Nutr 107 Suppl 2, S159-170, doi:10.1017/S0007114512001559 (2012).
22. Kang, J. X., Wang, J., Wu, L. , Kang, Z. B. Transgenic mice: fat-1 mice convert n-6 to n-3 fatty acids. Nature 427, 504, doi:10.1038/427504a (2004).
23. Couturier-Maillard, A. et al. NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J Clin Invest 123, 700-711, doi:10.1172/JCI62236 (2013).
24. Elinav, E. et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145, 745-757, doi:10.1016/j. cell.2011.04.022 (2011).
25. Malo, M. S. et al. Intestinal alkaline phosphatase preserves the normal homeostasis of gut microbiota. Gut 59, 1476-1484, doi:10.1136/gut.2010.211706 (2010).
26. Campbell, E. L. et al. Resolvin E1-induced intestinal alkaline phosphatase promotes resolution of inflammation through LPS detoxification. Proc Natl Acad Sci USA 107, 14298-14303, doi:10.1073/pnas.0914730107 (2010).
27. Shifrin, D. A., Jr. et al. Enterocyte microvillus-derived vesicles detoxify bacterial products and regulate epithelial-microbial interactions. Curr Biol 22, 627-631, doi:10.1016/j.cub.2012.02.022 (2012).
28. Koyama, I., Matsunaga, T., Harada, T., Hokari, S. , Komoda, T. Alkaline phosphatases reduce toxicity of lipopolysaccharides in vivo and in vitro through dephosphorylation. Clin Biochem 35, 455-461 (2002).
29. Chen, H. et al. Arabinoxylan in Wheat is More Responsible Than Cellulose for Promoting the Intestinal Barrier Function in Weaned Male Piglets. J Nutr, doi:10.3945/jn.114.201772 (2014).
30. Yang, C. et al. Lactoferrin up-regulates intestinal gene expression of brain-derived neurotrophic factors BDNF, UCHL1 and alkaline phosphatase activity to alleviate early weaning diarrhea in postnatal piglets. J Nutr Biochem 25, 834-842, doi:10.1016/j. jnutbio.2014.03.015 (2014).
31. Malo, M. S. et al. Intestinal alkaline phosphatase promotes gut bacterial growth by reducing the concentration of luminal nucleotide triphosphates. Am J Physiol Gastrointest Liver Physiol 306, G826-838, doi:10.1152/ajpgi.00357.2013 (2014).
32. Narisawa, S. et al. A novel phosphatase upregulated in Akp3 knockout mice. Am J Physiol Gastrointest Liver Physiol 293, G1068-1077, doi:10.1152/ajpgi.00073.2007 (2007).
33. Kaliannan, K. et al. Intestinal alkaline phosphatase prevents metabolic syndrome in mice. Proc Natl Acad Sci USA 110, 7003-7008, doi:10.1073/pnas.1220180110 (2013).
34. Ghosh, S. et al. Fish oil attenuates omega-6 polyunsaturated fatty acid-induced dysbiosis and infectious colitis but impairs LPS dephosphorylation activity causing sepsis. PLoS One 8, e55468, doi:10.1371/journal.pone.0055468 (2013).
35. Patterson, E. et al. Impact of dietary fatty acids on metabolic activity and host intestinal microbiota composition in C57BL/6J mice. Br J Nutr, 1-13, doi:10.1017/S0007114514000117 (2014).
36. Li, Q. et al. Fish oil enhances recovery of intestinal microbiota and epithelial integrity in chronic rejection of intestinal transplant. PLoS One 6, e20460, doi:10.1371/journal.pone.0020460 (2011).
37. Yu, H. N. et al. Effects of fish oil with a high content of n-3 polyunsaturated fatty acids on mouse gut microbiota. Arch Med Res 45, 195-202, doi:10.1016/j.arcmed.2014.03.008 (2014).
38. Thompson, L. , Spiller, R. C. Impact of polyunsaturated fatty acids on human colonic bacterial metabolism: an in vitro and in vivo study. Br J Nutr 74, 733-741 (1995).
39. Lalles, J. P. Intestinal alkaline phosphatase: multiple biological roles in maintenance of intestinal homeostasis and modulation by diet. Nutr Rev 68: 323-332, doi: 10.1111/j.1753-4887.2010.00292.x (2010).
40. Lalles, J. P. Intestinal alkaline phosphatase: novel functions and protective effects. Nutr Rev 72: 82-94, doi: 10.1111/nure.12082 (2014).
41. De Lisle, R. C., Mueller, R. , Boyd, M. Impaired mucosal barrier function in the small intestine of the cystic fibrosis mouse. J Pediatr Gastroenterol Nutr 53, 1371-379, doi:10.1097/MPG.0b013e318219c397 (2011).
42. Arnal, M.-E. et al. Maternal antibiotic-induced early changes in microbial colonization selectively modulate colonic permeability and inducible heat shock proteins, and digesta concentrations of alkaline phosphatase and TLR-stimulants in swine offspring. PLoS ONE 10: e0118092. doi:10.1371/journal.pone.0118092 (2015).
43. Sharma, U. et al. Implication of BBM lipid composition and fluidity in mitigated alkaline phosphatase activity in renal cell carcinoma. Mol Cell Biochem 369, 287-293, doi:10.1007/s11010-012-1391-y (2012).
44. Stenson, W. F. et al. Effects of dietary fish oil supplementation on membrane fluidity and enzyme activity in rat small intestine. Biochem J 263, 41-45 (1989).
45. Hudert, C. A. et al. Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis. Proc Natl Acad Sci USA 103, 11276-11281, doi:10.1073/pnas.0601280103 (2006).
46. Sanz, Y., Santacruz, A. , Gauffin, P. Gut microbiota in obesity and metabolic disorders. Proc Nutr Soc 69, 434-441, doi:10.1017/S0029665110001813 (2010).
47. Zhang, C. et al. Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice. ISME J 4, 232-241, doi:10.1038/ismej.2009.112 (2010).
48. Menon, R. et al. Diet complexity and estrogen receptor beta status affect the composition of the murine intestinal microbiota. Appl Environ Microbiol 79, 5763-5773, doi:10.1128/AEM.01182-13 (2013).
49. Yan, Y. et al. Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation. Immunity 38, 1154-1163, doi:10.1016/j.immuni.2013.05.015 (2013).
50. Romanatto, T., Fiamoncini, J., Wang, B., Curi, R. , Kang, J. X. Elevated tissue omega-3 fatty acid status prevents age-related glucose intolerance in fat-1 transgenic mice. Biochim Biophys Acta 1842, 186-191, doi:10.1016/j.bbadis.2013.10.017 (2014).
51. Reikvam, D. H. et al. Depletion of murine intestinal microbiota: effects on gut mucosa and epithelial gene expression. PLoS One 6, e17996, doi:10.1371/journal.pone.0017996 (2011).
52. Bel, S. et al. Reprogrammed and transmissible intestinal microbiota confer diminished susceptibility to induced colitis in TMF-/-mice. Proc Natl Acad Sci USA 111, 4964-4969, doi:10.1073/pnas.1319114111 (2014).
53. Prizont, R. , Konigsberg, N. Identification of bacterial glycosidases in rat cecal contents. Dig Dis Sci 26, 773-777 (1981).
54. Moss, A. K. et al. Intestinal alkaline phosphatase inhibits the proinflammatory nucleotide uridine diphosphate. Am J Physiol Gastrointest Liver Physiol 304, G597-604, doi:10.1152/ajpgi.00455.2012 (2013).
55. Peng, J. et al. Long term effect of gut microbiota transfer on diabetes development. J Autoimmun 53, 85-94, doi:10.1016/j. jaut.2014.03.005 (2014).
56. Alam, S. N. et al. Intestinal alkaline phosphatase prevents antibiotic-induced susceptibility to enteric pathogens. Ann Surg 259, 715-722, doi:10.1097/SLA.0b013e31828fae14 (2014).
57. Cowan, T. E. et al. Chronic coffee consumption in the diet-induced obese rat: impact on gut microbiota and serum metabolomics. J Nutr Biochem 25, 489-495, doi:10.1016/j.jnutbio.2013.12.009 (2014).
58. Louie, T. J. et al. Fidaxomicin preserves the intestinal microbiome during and after treatment of Clostridium difficile infection (CDI) and reduces both toxin reexpression and recurrence of CDI. Clin Infect Dis 55 Suppl 2, S132-142, doi:10.1093/cid/cis338 (2012).
59. Kim, K. J., Lee, O. H. , Lee, B. Y. Low-molecular-weight fucoidan regulates myogenic differentiation through the mitogenactivated protein kinase pathway in C2C12 cells. Br J Nutr 106, 1836-1844, doi:10.1017/S0007114511002534 (2011).
60. Kang, J. X. , Wang, J. A simplified method for analysis of polyunsaturated fatty acids. BMC Biochem 6, 5, doi:10.1186/1471-2091-6-5 (2005).
61. Mohammadi, A. , Oshaghi, E. A. Effect of garlic on lipid profile and expression of LXR alpha in intestine and liver of hypercholesterolemic mice. J Diabetes Metab Disord 13, 20, doi:10.1186/2251-6581-13-20 (2014).